Equity

Will your company cut your benefits or your coworkers first? (re-post)

Oct 21, 2022
Rebecca Szkutak, a Senior Writer at TechCrunch, dives into the current startup landscape. She discusses the FDA's game-changing decision to allow over-the-counter hearing aid sales, paving the way for innovation. The conversation also highlights how startups in employee benefits could weather economic cuts while maintaining essential support. Regional investment disparities are analyzed, showcasing the Midwest's potential versus the Southeast's lower valuations. Tune in for a lively exploration of entrepreneurial resilience in uncertain times!
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Neumann's Return and Funding Concerns

  • Adam Neumann's comeback wasn't surprising, but the size of Andreessen Horowitz's $350 million check was.
  • The follow-on funding aspect is crucial, especially considering SoftBank's recent valuation concerns.
INSIGHT

Over-the-Counter Hearing Aids: A Win for Innovation

  • The FDA's decision to allow over-the-counter hearing aids is a win for the industry and consumers.
  • This ruling opens doors for startup innovation, potentially lowering costs and reducing stigma.
ANECDOTE

Startups Ready for Hearing Aid Innovation

  • Some startups were already prepared for this ruling and have completed the FDA approval process.
  • New hearing aid products could be available as early as three to five months from now.
Get the Snipd Podcast app to discover more snips from this episode
Get the app